OTITIS MEDIA WITH EFFUSION
St George ENT
-OM: - most common disease of children,
- leading cause of hearing loss in children, and the
- most frequent indication for antimicrobial/surgical Rx in children. -costs of therapy over $1 billion expended each year US
more than I million operative procedures per yr in US
-85% of children experience at least one episode of OM
-causes of OM are multiple
-predisposing factors are:
-young age, maleness, bottle feeding, crowded living, heredity,
allergy, socioeconomic status, smoking by mother,
parental history of otitis media, viral infections at home,
-associated conditions (cleft palate, immunodef. ciliary dyskinesia,Down syndrome, &CF).
NB: less common in black (due to differences in size & angulation of ET
NB: birth wt not significant & breast feeding protective only until stopped
BACKGROUND
Definitions
-OM: generic term for inflam’n within middle ear cleft behind intact TM
-Middle ear effusion (MEE) : generic term for liquid in middle ear cleft
regardless of etiology.
-Acute otitis media (AOM) : symptoms & signs of acute infection
(middle ear effusion with fever; pain; red, bulging TM).
-Chronic otitis media with effusion (OME) or "glue ear":
( <=>chronic secretory otitis media, chronic serous otitis media),
(middle ear effusion without pain, redness, or bulging TM)
- Others: chronic suppurative otitis media with:
-permanent perforation of TM or
-cholesteatoma.
Clinical and functional anatomy
-middle ear cleft: continuous space from nasopharyngeal orifice of ET to
the furthermost mastoid air cells.
-three main segments are :
-ET;
-middle ear (tympanum);
-air cells of the mastoid, petrosa, and related areas.
-mucosal lining of middle ear cleft varies from
-thick,ciliated, respir. epth elium of ET & anterior tympanum to
-thin, featureless cuboidal epithelium in mastoid cells.
-middle ears of pts with OM=> hyperplasia & Ý in goblet cells Sade ‘66 NB: thought to predispose to formation of effusion.
-Tympanic mucous blanket is swept twd NPx by action of ciliated epth =>secretions/particles are cleared from mid.ear into NPx via ET
-ET:
-normally closed to protect middle ear from entry of unwanted material
-opens with swallowing & other maneuvers due to TVP m contraction
=>equilibration of pressure in middle ear to ambient pressure
-three classic functions:
aeration, clearance, and protection of the middle ear.
TYPES
*(A) OTITIS MEDIA
PATHOPHYSIOLOGY
-historically linked with abnormalities of eustachian tube function.
-Hypotheses:
-early studies suggested obstruction(underaeration) of ET was the prob
-new work=>suggests failure of protection (abN patent or compliant ET) => bacteria enter ME
=> AOM
NB: Tubal obstruction with failure of clearance may be 2’ry rather than primary processes
* (B) ACUTE OTITIS MEDIA
-a bacterial disorder (majority)
Streptococcus pneumoniae
Haemophilus influenzae
Branhamella catarrhalis
Streptococcus pyogenes
Staphylococcus aureus
Staphylococcus epidermidis
-viruses in 20% of early cases,
(in some cases as sole agent, but more often with bacteria).
-Pathogenic bacteria subsequently are found in nasopharynges of 97% of patients with AOM,
with correspondence to organisms in middle ear effusion in 69% (Howie and Ploussard, 1972).
-Ad’s of children with recurrent AOM contains pathogenic bacteria in clinically significant amnts
-Ad’s (pharyngeal tonsil) forms uppermost part of Waldeyer’s ring
-is covered by resp epith rich in goblet cells
-numerous surface folds
-abundant lymphocytes are found within, esp. on crests of folds.
-is fully developed at 7th month, & increases in size until year 5
-nasal mucociliary blanket carries material posteriorly across ads.
-regarded as a B-cell organ.
-There is a significant age correlation with middle-ear pathogens in the
nasopharynges of clinically disease-free children;
-57% of under-2-year-old group were culture positive VS
-40% of 2 to 15-year-old children.
-Thus=> adenoid in AOM is a bacterial reservoir in nasopharynx.
- route of entry of NP bugs into middle ear is via reflux from ET:
-during swallowing (seen radiographically Bluestone 1972).
-facl’td by nose blowing & closed-nose swallowing,(Toynbee mnv)
-aspiration into middle ear due to negative pressure (eg sniffing)
-patulous eustachian tubes
-young children have shorter, straighter, more compliant ET’s
- adenoid is elevated by soft palate during swallowing,
\ when big may obstruct post choanae & Þ Ý NP P Þ reflux.
-Ad’s size in children with OM did not differ from control either radiographically (Hibbert 82) or
by weight (Gerwat, 1975)
-no difference in recurrence of effusion in kids with large vs small ads
-it is unnecessary to postulate ET obstruction as a necessary precedent for AOM to occur
-never been shown that adenoid physically obstructs the ET; in fact, has been shown it doesn’t.
-Study: Honjo (1988) studied 52 OME kids & compared ET fnct’n in pts with a large adenoid (which appeared to obstruct ET on scope )
vs
pts with a clearly open tube.
Result Þ No difference in opening pressure or in positive pressure
equalization was noted between the two groups.
Þ No diff in ET ventilation function pre- & after adnoidectomy
Takahashi (1987) studied 10 adults with OME using thin catheter
Þ site of ET obstr’n is at distal part of cartilag tube (5-15 mm from end orifice),
rather than at the orifice proper.
-Improvement in ET, does occur after adenoidectomy (Bluestone 1972)
*(C) OTITIS MEDIA WITH EFFUSION
- ET dysfuntion nearly always found in OME
-ligation of ET in animals Þ MEE
-2 categories of OME:
(1) persistent MEE following an acute effusion
(2) secretary otitis media.
-Pathophysiology:
- failure of the middle ear clearance mechanism.
-Factors involved include:
-ciliary dysfunction, mucosal edema & hyperplasia,
viscosity of secretions, middle ear/NP pressure gradient.
-Barotrauma: occurs when mid ear P becomes rapidly < atm P
Þ a clear, watery transudate
-Seen sporadically due to viral infection
-Cleft palate (nearly a universal finding)
(Mech: defect is related to function of TVP m, which lacks its usual insertion into soft
palate,Þ unable to open ET properly on swallowing Þ functional obstruction )
-Histopathology
-temporal bone in OM shows:
-vascular dilt’n & prolif’n, mononucl cells,
-epith thickening & metaplasia; gland formtn, edema & exudation
Sequelae
-adverse effects of OME on hearing & development
-otologic sequelae: permanent perforation, CSOM, tympanosclerosis, adhesive OM,
ossicular necrosis, retraction pockets cholesteatoma, & SNHL
DIAGNOSIS
Hx: -Older children Þ earache,
-InfantsÞ fussy, sleep poorly, and pull at affected ear, fever
-may be completely asymptomatic.
Otoscopy
1. AOM
-redness and bulging TM
-as effusion develops, drum mobility decreases
-severe cases no landmarks may be visible
-if process continuesÞ necrosis of TM occurs Þ perforation.
NB: -massive necrosis of drumhead is now rare
-necrotizing streptococcal infct’n Þ permanent perforation.
-pneumatic otoscope: pressures of 1-2mm H20 Þ detectable motion
-clinical variants of AOM:
- Myringitis: inflammation of TM without MEE
- Bullous myringitis:
- adults and children
- most cases associated with same pathobacteria as AOM
some with Mycoplasma pneumoniae
-pain is outstanding feature, not relieved by opening bullae.
2. OME
-retracted, hypomobile/immobile TM
-dark, fluid-filled drum (obscurring vision of incus long process)
Audiometry
- moderate conductive hearing loss
-studies show variable range of hearing loss in OM, with AC thresholds averaging 27.5 dB
-hearing loss due to MEE is a principal indication for surgical treatment
TREATMENT
1. Acute otitis media
a. Antimicrobial therapy
-important to consider using B lactamase-resistant agents as first line
-duration of therapy: 10-day course
b. Adjunct medical therapy
-nasal decongestant open the airway, may be used for short periods,but prolonged use may worsen rather than improve airway b/c of rebound.
c. Tympanocentesis
-Knowledge of specific organism is important for:
(1) premature newborns
(2) immunocompromised patients
(3) patients with progression of Sx & signs while on Rx
(4) cases with intracranial infection
(5) research subjects
-method: - 18-gauge spinal needle attached to a 1-ml tuberculin syringe.
- no anesthetic is necessary
- needle inserted into anteroinferior quadrant of TM
d. Myringotomy
- AOM myringotomy, has proven to be of limited value.
-promptly relieves severe pain
-adds little to remission of inf’n or clearance of MEE.Englehard1989
-report of van Buchem (1981) has been cited as showed:
Þ no difference in outcome with AOM whether A/B, myringotomy, both, or neither used.
(NB:large amt of methodologic flaws)
e. Follow-up
-impt: i. to assure infection is responding to AB’s
ii. to determine that the MEE has resolved
iii. important to exclude meningitis
-Therefore, a 3-day check is performed to determine response
a 2-week check is to determine if MEE has cleared
-Natural history of AOM Þ approx 1/2 ears will have cleared by 2/52
-little evidence to suggest prolonged/repeated therapy is useful
-if TM has ruptured, indicating a severe episode,
Þ continue AB’s until drainage has ceased & TM has sealed.
f. Recurrence & Prophylaxis
-Perrin (1974) & Varsano (1985)Þ sulfisoxazole chemoprevention of AOM -Casselbrant, 1990 Þ daily dose of amoxicillin, 20 mg/kg, for 3-6 mths
-Indication for prophylaxis is 3 or more episodes of AOM in 6/12 period.
-If develop recurrent AOM while on prophylaxis Þ Sx.
-Adenoidectomy should be an effective preventive:
-San Antonio trial (Gates 1987), number of episodes of AOM in
2 adenoidectomy gps did not differ from 2 nonadenoidectomy gps
g. Complications
see mastoiditis compln notes
2. Otitis media with effusion
a. Antimicrobial therapy
-MEE is known to contain viable, pathogenic bacteria (Liu et al., 1975).
\ Antimicrobial therapy is logical
-kids with asymptomatic OME discovered by screeningÞ recomm’d.
-followed by > 1-month observation period.
-If improved Þ second course or additional observation
-If no change at I month Þ Sx
b. Antihistamines and decongestants
-no routine use of decongestants in OME ( study by Cantekin 1983)
-steroid Rx of OME is experimental but worthy of continued study.
c. Middle ear inflation
- ET cathetrz’n (Politzer's maneuver) or autoinflation (Toynbee's mnvr)
Þ not generally used.
- Transiently good, but long-term net effect bad
Reason: it worsens the (-’ve) middle ear P pressure b/c the excess air injected into middle ear
passes out the ET, & the O2 remaining is absorbed through middle ear mucosa
-Important to remember gas in middle ear differs substantially from air, being hypercapnic and hypoxic, with gas tension values similar to arterial blood (Segal et al., 1983).
-Ex-vacuo theory : O2 in mid ear is continually absorbed, until replaced
by the ingress of nasopharyngeal air with swallowing.
Surgical therapy
-Surgical therapy does not cure patients with OME, but substantially reduces morbidity when
medical therapy has failed.
-OME & hearing loss persisting > 90-120 days with adequate A/B Rx Þ Sx is recommended.
-The time criterion is tempered by season.
-In Autumn Sx > Spring b/c of higher chance of URTI
-Types of procedures:
-Myringotomy +/- tubes, adenoidectomy +/- tonsillectomy
NB: tonsillectomy has no additional effect on MEE over adenoidectomy alone in cases of
OME (Maw, 1983)
-Myringotomy and suction alone:
- results not effective (Gates 1985; Mandel 1989).
-Tympanostomy tubes.
- introduced by Armstrong in 1954
Þ improved hearing & less AOM
- complications of tubes Þ purulent d/c, recurrent effusion, permanent perf’n,
(short-term tubes app 1%)( up to 5% longer term, bigger diam tubes)
-Long Tshaped tubes introduced by Goode (1973).
-Short have retention times of < year VS T-shaped tubes for years
-Experimental evidence Þ mucosal hyperplasia of tympanum revert to
more normal condition with aeration (Sade, 1966).
Technical considerations.
-Antibiotic drops often used after TT insertion. These have not been
associated with SNHL in humans (but have in experimental animals),
b/c of diff’s in anatomy of RW niche & membrane (Morizono, 1990).
Adenoidectomy. recent studies have confirmed its effectiveness
(Gates 1987; Maw, 1983; Paradise 1990).
Rationale for adenoidectomy.
-1st chief rationale is enlargement Þ nasal obstructn & mouth breathing.
-removal should lessen ET reflux
-removal for OM on size alone, has little scientific basis b/c ad & T enlargement results from
clonal expansion of immunocompetent cells (Fujiyoshi et al., 1989).\ large ad’s may be more
immunocompetent than small ad’s b/c chronic infection is associated with cellular depletion (Bernstein, 1990).
-3 separate studies (Gates 1987; Maw, 1985; Paradise 1990)
Þ effect of adenoidectomy on OM is independent of size.
-2nd classic rationale is improvement in ET function.
-In children with hypercompliant ET’s, adenoidectomy may Ý reflux.
-3rd and most current rationale is removal of chronically infected ad’s
to eliminate a nasopharyngea source of infection (Gates 1988).
Efficacy
-principal studies cited as showing a lack of effect of adenoidectomy are
Þ (Roydhouse 1980), FiellauNikolajsen 1983), Widemar 1985).
-studies demonstrating a significant effect from adenoidectomy are
Þ Maw (1983), Gates 1987), and Paradise 1990).
Technical considerations
-goal of adenoidectomy is complete removal of midline adenoid pad Þ smooth reepithelialization
of the nasopharynx.
-must avoid direct injury to torus tubarius ( Rosenmuller's fossa) that might Þ stenosis.
-most common complication of adenoidectomy is postop bleeding.
- 0.4% require operative treatment for bleeding (esp 1st 6hrs postop)
-Transient VPI may occur after R/O large ads but resolves in most
(most cases of postop VPI are due to undetected submuc cleft pal )
-occult submuc cleft is more obvious on post than ant surface of palate -it is clear that no major systemic immunologic deficiencies result from Ts & As (Siegel, 1984).
B
ibliography:
Cummings, C. Otolaryngology. c
hapter 156Gates Current Therapeutics
Scott Brown, , Otolaryngology
Schucknect, Pathology of the Ear
| HOME |
Disclaimer
Please note: The above is intended as a general guideline only for Dr. Becvarovski’s patients.
This material should not be used for purposes of diagnosis or treatment without consulting a physician.
Each patient is an individual and should be treated accordingly.
Please contact our rooms if you are concerned or require any further information.
Dr Zoran Becvarovski MBBS, FRACS
Consulting Rooms Hospital Appointments
St George Private Medical Complex St George Public Hospital
Suite 7A, Level 5, St George Private Hospital
1 South Street Kogarah 2217 Hurstville Community Private Hospital
Telephone: 9553 0066
Fax: 9553 0444
![]()